RACGP demands ‘clarity’ on COVID-19 vaccine indemnity deals
GPs are concerned about the stress a potential lawsuit could bring, college president Dr Karen Price says
The Federal Government should provide more clarity on its indemnity arrangements for AstraZeneca’s COVID-19 vaccine to quell GP uncertainty, says the RACGP president.
ATAGI’s declaration of a “likely causal link” between the vaccine and rare blood clots, what it has dubbed thrombosis with thrombocytopenia syndrome (TTS), threw Australia’s vaccination campaign into disarray last week.
